Log in to save to my catalogue

Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—...

Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5487581855704e0c8a5088a69a4388c6

Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—a contribution from the ConcePTION project

About this item

Full title

Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—a contribution from the ConcePTION project

Publisher

England: BMJ Publishing Group Ltd

Journal title

BMJ paediatrics open, 2024-04, Vol.8 (1), p.e002385

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

IntroductionBreastfeeding is beneficial for the health of the mother and child. However, at least 50% of postpartum women need pharmacotherapy, and this number is rising due to the increasing prevalence of chronic diseases and pregnancies at a later age. Making informed decisions on medicine use while breastfeeding is often challenging, considering...

Alternative Titles

Full title

Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol—a contribution from the ConcePTION project

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5487581855704e0c8a5088a69a4388c6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5487581855704e0c8a5088a69a4388c6

Other Identifiers

ISSN

2399-9772

E-ISSN

2399-9772

DOI

10.1136/bmjpo-2023-002385

How to access this item